Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FAM86LP (family with sequence similarity 86 member L, pseudogene) is classified as a human pseudogene, indicating it is a genomic DNA sequence similar to a functional gene but is not transcribed into a functional protein. There are no published biological functions, associated disease roles, or reports of drugs interacting with this locus. The gene is annotated in databases such as HGNC (HGNC:44099), and is not regarded as a receptor, enzyme, or other druggable molecular target[1][7]. Note: - The annotation “pseudogene” means that the gene is generally non-functional at the protein or RNA level, and standard drug discovery or therapeutic targeting approaches do not apply. - No evidence supports the use of FAM86LP as a disease biomarker or clinical target. - If you expected information on a functional protein or target, this gene does not meet those criteria. This assessment is made based on reference gene databases and molecular annotation sources[1][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 86 member L, pseudogene (FAM86LP).